News
SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and ...
Vektor Medical's vMap receives FDA clearance. vMap is the first rapid, non-invasive arrhythmia-source mapping system that uses only a 12-lead ECG.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback